ERRγ, a Novel Biomarker, Associates with Pathoglycemia of Endometrial Cancer to Predict Myometrial Invasion

Figure 2

(a–c) Expression of ERRγ in Uterine Corpus Endometrial Carcinoma (UCEC) in TCGA database. (d–f) Expression of ERRγ in UCEC in the CPTAC database. (g) Immunohistochemical staining for hematoxylin/eosin (HE) and ERRγ on normal and tumor tissues (magnification, ×50, ×200). (h) Expression of ERRγ in EC and normal endometrial tissue. (i–m) Difference expression of ERRγ in tumor tissue with different clinical features.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)